Malva sylvestris L. (commonly known as mallow) has been widely used in traditional Tibetan formulations to treat allergic rhinitis (AR), and malvidin is a key anti-inflammation constituent of this plant.
Objective
The present study aimed to evaluate the potential therapeutic effect and mechanism of malvidin in an AR mouse model.
Methods
Malvidin's efficacy was evaluated in an AR mouse model induced by ovalbumin (OVA) sensitization and challenge. The factors, such as nasal symptoms, serum OVA-specific immunoglobulin E (IgE) levels, histological changes in the nasal mucosa, and expressions of Th1, Th2, Th17, and Tregs and their cytokines, were assessed. Western blotting was used to analyze the effect of malvidin on signal transducer and activator of transcription 6 (STAT6) and GATA3 expression levels.
Results
Malvidin reduced the allergic symptoms and serum levels of OVA-specific IgE in the AR model. Histological analysis indicated that malvidin alleviates nasal mucosal edema, eosinophil infiltration, and goblet cell proliferation. In addition, it altered the expression of Th1/Th2/Th17-related cytokines, enhanced the Treg population, and reduced Th2-mediated immunity by suppressing the phosphorylation of STAT6 and expression of the GATA3 protein.
Conclusions
Malvidin significantly improved allergic symptoms in an OVA-induced AR mouse model by modulating Th1/Th2 immune responses and suppressing the STAT6/GATA3 pathway, indicating its potential as a naturally sourced agent for AR management.
DingYWangYZhangY, et al.Alpha-linolenic acid improves nasal mucosa epithelial barrier function in allergic rhinitis by arresting CD4+ T cell differentiation via IL-4Rα-JAK2-STAT3 pathway. Phytomedicine. 2023;116:154825.
2.
DrazdauskaitėGLayhadiJAShamjiMH. Mechanisms of allergen immunotherapy in allergic rhinitis. Curr Allergy Asthma Rep.2020;21(1):2.
3.
YinXChenSEisenbarthSC. Dendritic cell regulation of T helper cells. Annu Rev Immunol.2021;39:759-790.
4.
RuterbuschMPrunerKBShehataL, et al.In vivo CD4+ T cell differentiation and function: revisiting the Th1/Th2 paradigm. Annu Rev Immunol.2020;38:705-725.
5.
DongC. Cytokine regulation and function in T cells. Annu Rev Immunol.2021;39:51-76.
6.
WynnTA. Type 2 cytokines: mechanisms and therapeutic strategies: 5. Nat Rev Immunol.2015;15(5):271-282.
7.
BingZJin-TaoDFengL, et al.Effect of Astragalus membranaceus in ovalbumin-induced allergic rhinitis mouse model. Am J Rhinol Allergy.2019;33(4):420-432.
8.
YuSHanBLiuS, et al.Derp1-modified dendritic cells attenuate allergic inflammation by regulating the development of T helper type1(Th1)/Th2 cells and regulatory T cells in a murine model of allergic rhinitis. Mol Immunol.2017;90:172-181.
9.
NguyenJKAustinEHuangA, et al.The IL-4/IL-13 axis in skin fibrosis and scarring: mechanistic concepts and therapeutic targets. Arch Dermatol Res.2020;312(2):81-92.
10.
BousquetJAntoJMBachertC, et al.Allergic rhinitis. Nat Rev Dis Primers. 2020;6(1):1-17.
11.
PhilipsRLWangYCheonH, et al.The JAK-STAT pathway at 30: much learned, much more to do. Cell. 2022;185(21):3857-3876.
12.
g.yu thog rnying ma yon tan mgon po. rGyud bzhi [M/OL]. Tibet People's Publishing House; 1982.
13.
MousaviSMHashemiSABehbudiG, et al.A review on health benefits of Malva sylvestris L. Nutritional compounds for metabolites, antioxidants, and anti-inflammatory, anticancer, and antimicrobial applications. Evid Based Complement Alternat Med. 2021;2021:5548404.
14.
PrudenteASSponchiadoGMendesDAGB, et al.Pre-clinical efficacy assessment of Malva sylvestris on chronic skin inflammation. Biomed Pharmacother.2017;93:852-860.
15.
BatihaGE-STeneSTTeiboJO, et al.The phytochemical profiling, pharmacological activities, and safety of Malva sylvestris: a review. Naunyn Schmiedebergs Arch Pharmacol. 2023;396(3):421-440.
16.
DaiTShiKChenG, et al.Malvidin attenuates pain and inflammation in rats with osteoarthritis by suppressing NF-κB signaling pathway. Inflamm Res. 2017;66(12):1075-1084.
17.
SakthivelKMKokilavaniKKathirvelanC, et al.Malvidin abrogates oxidative stress and inflammatory mediators to inhibit solid and ascitic tumor development in mice. J Environ Pathol Toxicol Oncol.2020;39(3):247-260.
18.
FanHCuiJLiuF, et al.Malvidin protects against lipopolysaccharide-induced acute liver injury in mice via regulating Nrf2 and NLRP3 pathways and suppressing apoptosis and autophagy. Eur J Pharmacol.2022;933:175252.
19.
PinartMBenetMAnnesi-MaesanoI, et al.Comorbidity of eczema, rhinitis, and asthma in IgE-sensitised and non-IgE-sensitised children in MeDALL: a population-based cohort study. Lancet Respir Med.2014;2(2):131-140.
20.
HumbertMBousquetJBachertC, et al.IgE-mediated multimorbidities in allergic asthma and the potential for omalizumab therapy. J Allergy Clin Immunol Pract. 2019;7(5):1418-1429.
21.
NiuXYangYYuJ, et al.Panlongqi tablet suppresses adjuvant-induced rheumatoid arthritis by inhibiting the inflammatory reponse in vivo and in vitro. J Ethnopharmacol.2023;308:116250.
WangJZhouYZhangH, et al.Pathogenesis of allergic diseases and implications for therapeutic interventions. Signal Transduct Target Ther. 2023;8(1):1-30.
24.
PatelPSalapatekAMTantrySK. Effect of olopatadine-mometasone combination nasal spray on seasonal allergic rhinitis symptoms in an environmental exposure chamber study. Ann Allergy Asthma Immunol.2019;122(2):160-166.e1.
25.
XuSKongY-GJiaoW-E, et al.Tangeretin promotes regulatory T cell differentiation by inhibiting Notch1/Jagged1 signaling in allergic rhinitis. Int Immunopharmacol.2019;72:402-412.
26.
FuMXuYChenY, et al.Evaluation of bioactive flavonoids and antioxidant activity in pericarpium Citri reticulatae (Citrus reticulata ‘chachi’) during storage. Food Chem.2017;230:649-656.
27.
ZhuMLiangZWangT, et al.Th1/Th2/Th17 cells imbalance in patients with asthma with and without psychological symptoms. Allergy Asthma Proc.2016;37(2):148-156.
28.
DolffSBijlMHuitemaMG, et al.Disturbed Th1, Th2, Th17 and treg balance in patients with systemic lupus erythematosus. Clin Immunol.2011;141(2):197-204.
29.
TalaatRMMohamedSFBassyouniIH, et al.Th1/Th2/Th17/treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: correlation with disease activity. Cytokine. 2015;72(2):146-153.
30.
ZhangH-LZhengX-YZhuJ. Th1/Th2/Th17/treg cytokines in Guillain–Barré syndrome and experimental autoimmune neuritis. Cytokine Growth Factor Rev.2013;24(5):443-453.
31.
LuoWHuJXuW, et al.Distinct spatial and temporal roles for Th1, Th2, and Th17 cells in asthma. Front Immunol.2022;13:974066.
32.
ChenQZhongHChenWC, et al.Different expression patterns of plasma Th1-, Th2-, Th17- and Th22-related cytokines correlate with serum autoreactivity and allergen sensitivity in chronic spontaneous Urticaria. J Eur Acad Dermatol Venereol.2018;32(3):441-448.
33.
EndoYHiraharaKYagiR, et al.Pathogenic memory type Th2 cells in allergic inflammation. Trends Immunol.2014;35(2):69-78.
34.
JutelMAkdisMBlaserK, et al.Mechanisms of allergen specific immunotherapy—T-cell tolerance and more. Allergy. 2006;61(7):796-807.
35.
QiaoY-LJiaoW-EXuS, et al.Allergen immunotherapy enhances the immunosuppressive effects of treg to alleviate allergic rhinitis by decreasing PU-1+ treg cell numbers. Int Immunopharmacol.2022;112:109187.
36.
ZhangYLanFZhangL. Update on pathomechanisms and treatments in allergic rhinitis. Allergy. 2022;77(11):3309-3319.
37.
SurDKScandaleS. Treatment of allergic rhinitis. Am Fam Physician.2010;81(12):1440-1446.
38.
KalinerMABergerWERatnerPH, et al.The efficacy of intranasal antihistamines in the treatment of allergic rhinitis. Ann Allergy Asthma Immunol.2011;106(2, Supplement):S6-S11.
39.
KomlósiZIvan de VeenWKovácsN, et al.Cellular and molecular mechanisms of allergic asthma. Mol Asp Med.2022;85:100995.
40.
TamuraKSuzukiMArakawaH, et al.Linkage and association studies of STAT6 gene polymorphisms and allergic diseases. Int Arch Allergy Appl Immunol.2003;131(1):33-38.
41.
KarpathiouGPapoudou-BaiAFerrandE, et al.STAT6: a review of a signaling pathway implicated in various diseases with a special emphasis in its usefulness in pathology. Pathol Res Pract. 2021;223:153477.
ZhuJYamaneHCote-SierraJ, et al.GATA-3 promotes Th2 responses through three different mechanisms: induction of Th2 cytokine production, selective growth of Th2 cells and inhibition of Th1 cell-specific factors. Cell Res.2006;16(1):3-10.
44.
KatoHPerlA. Double-edged sword: interleukin-2 promotes T regulatory cell differentiation but also expands interleukin-13- and interferon-γ-producing CD8+ T cells via STAT6-GATA-3 axis in systemic lupus erythematosus. Front Immunol.2021;12:635531.
45.
XiaodongXTaoLJianminL, et al.Crocin inhibits the type 2 inflammatory response produced by ILC2 s in eosinophilic nasal polyps. Am J Rhinol Allergy. 2023;37(6):656-669.
